Navigation Links
Ceregene Reports New Findings Regarding How Parkinson's Brains Respond to Neurotrophic Factors
Date:2/15/2011

further support the safety and clinical benefit of CERE-120.

For more information, see PDTrials.org or log onto Ceregene's web site (www.Ceregene.com).

About Parkinson's Disease

Parkinson's disease is a progressive movement disorder that affects a million people in the United States.  Its main symptoms, stiffness, tremors and slowed movements and gait, are caused by a loss of dopamine-containing nerve cells in the substantia nigra, which project their axons to the putamen.  Dopamine is a neurotransmitter involved in controlling movement and coordination, so Parkinson's patients exhibit a progressive inability to initiate and control physical movements.  There is currently no treatment that can reverse the degeneration of these neurons, let alone cure Parkinson's disease.

About Ceregene

Ceregene, Inc. is a San Diego-based biotechnology company focused on the delivery of nervous system growth (neurotrophic) factors for the treatment of neurodegenerative and retinal disorders using gene delivery.  Ceregene's clinical programs include CERE-110, an AAV2 based vector expressing nerve growth factor (NGF) currently in a multi-center, controlled Phase 2 study for the treatment of Alzheimer's disease (in collaboration with the ADCS), and CERE-120 (AAV2-Neurturin) for Parkinson's disease.  Ceregene was launched in January 2001.  The company's investors include Alta Partners, MPM Capital, Hamilton BioVentures, Investor Growth Capital, California Technology Partners and BioSante Pharmaceuticals (Nasdaq: BPAX).


'/>"/>
SOURCE Ceregene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients
2. Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinsons Disease
3. SeraCare Reports First Quarter Fiscal Year 2011 Results
4. Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results
5. YM BioSciences Reports Fiscal Second Quarter 2011 Operational and Financial Results
6. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Results
7. ERT Reports Fourth Quarter and Full Year 2010 Operating Results on March 1, 2011
8. Sigma-Aldrich (Nasdaq: SIAL) Reports Q4 and Full Year 2010 Diluted EPS of $0.76 and $3.12, Respectively. Q4 and Full Year 2010 Adjusted Diluted EPS Were $0.83 and $3.31, Respectively. Q4 Sales Set New Quarterly High. 2011 Diluted EPS Expected to be
9. Pharmacyclics Reports Recent Developments and Financial Results for Fiscal Second Quarter 2011
10. Codexis Reports Fourth Quarter and Full Year 2010 Results
11. Sangamo BioSciences Reports Fourth Quarter and Full Year 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)... 23, 2015 Delpor, Inc. (Delpor), a ... the United States Patent and Trademark Office has issued ... technology. US Pat. No. 8,986,727 was issued ... drug delivery device for the sustained release of ... for the sustained (zero-order) release of large and small ...
(Date:4/22/2015)... , April 22, 2015  Sangamo BioSciences, Inc. (NASDAQ: ... financial results and accomplishments. For the first ... net loss of $5.3 million, or $0.08 per share, ... $0.12 per share, for the same period in 2014. ... cash equivalents, marketable securities and interest receivable of $226.1 ...
(Date:4/22/2015)... 22, 2015   MPIRICA Health Inc. , ... in Series A financing from the McQuinn Trust, ... accelerate consumer and employer awareness of MPIRICA.com, delivering ... over 4,800 U.S. hospitals. "As a ... very concerned about choosing the hospital and surgeon ...
(Date:4/22/2015)... , April 22, 2015 Steep Hill, ... announced today that it has opened an investment ... growth and expansion.  The common stock investment round ... 506(c), a law intended to encourage funding of ... to 506(c), small businesses largely relied on friends ...
Breaking Biology Technology:Delpor, Inc. Announces the Issuance of 2 New US Patents Based on its Nanopore Technology which Enables the Sustained Release of Drugs from a Small Implant Device 2Delpor, Inc. Announces the Issuance of 2 New US Patents Based on its Nanopore Technology which Enables the Sustained Release of Drugs from a Small Implant Device 3Sangamo BioSciences Reports First Quarter 2015 Financial Results 2Sangamo BioSciences Reports First Quarter 2015 Financial Results 3Sangamo BioSciences Reports First Quarter 2015 Financial Results 4Sangamo BioSciences Reports First Quarter 2015 Financial Results 5Sangamo BioSciences Reports First Quarter 2015 Financial Results 6Sangamo BioSciences Reports First Quarter 2015 Financial Results 7Sangamo BioSciences Reports First Quarter 2015 Financial Results 8MPIRICA Health Inc. Secures $1.6M to Promote FICO-Like Quality Scores for Surgeries 2Steep Hill Launches $5M Limited Stock Offering 2Steep Hill Launches $5M Limited Stock Offering 3
... HOPKINTON, Mass. , June 25 Caliper Life Sciences, ... services for drug discovery and life sciences research, hosted its 2010 ... and 10. This thought-leadership conference is focused on sharing knowledge, ... leading to the next generation of breakthrough diagnostics and therapies. , ...
... sequencing and analysis of the human body louse genome, ... Proceedings of the National Academy of Sciences (PNAS), ... disease-vector insect. The project involved more than 70 international ... of Geneva Medical School and the SIB Swiss Institute ...
... of an electron to exist in two places at once ... silicon - for the first time. The research findings - ... the University of Surrey, UCL (University College) London, Heriot-Watt University ... Utrecht - marks a significant step towards the making of ...
Cached Biology Technology:Caliper Owners Group Meeting Showcases Critical Role of Biopharma and Academic Researchers for Improving Healthcare and Quality of Life 2Caliper Owners Group Meeting Showcases Critical Role of Biopharma and Academic Researchers for Improving Healthcare and Quality of Life 3Sequencing of the human body louse genome 2'Quantum computer' a stage closer with silicon breakthrough, reports Nature journal 2
(Date:3/24/2015)... 2015   NexID Biometrics LLC, whose spoof-mitigation ... today announced the beginning of shipments of version 2.0 ... The company, based in Potsdam, N.Y. ... Expo, which began here today at the Walter E. ... of its SDK boosts the accuracy rate range to ...
(Date:3/23/2015)... , March 23, 2015   HOYOS Labs ... management company, today announced that the Company will demonstrate ... both enterprise and consumers at Connect:ID on March 23 ... HOYOS Labs will highlight the IEEE Biometric Open ... ; and enterprise access control system. BOPS was ...
(Date:3/20/2015)... Mar. 20, 2015 Research and Markets ... of the "India Sensors Market Forecast and ... The sensor market is projected to grow ... Consumer electronics, automotive, industrial and healthcare sectors ... the country. In addition, adoption of MEMS technology ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3
... National Heart, Lung and Blood Institute, one of the ... the Johns Hopkins University School of Medicine each approximately ... two Programs of Excellence in Glycosciences. Gerald Hart, Ph.D., ... of pharmacology and molecular sciences, will lead these independent ...
... every day could help control Type 2 diabetes and ... Michael,s Hospital and the University of Toronto. In ... Care , a team of researchers led by Dr. ... St. Michael,s Hospital Risk Factor Modification Centre) reports that ...
... 07/07/11, Clearwater Beach, FL. Research to be ... for the Study of Ingestive Behavior (SSIB), the foremost ... drinking behavior, suggests that people can become dependent on ... of consumption, similar to the behaviors we observe in ...
Cached Biology News:Johns Hopkins researchers awarded $32 million 2A 'nutty' solution to type 2 diabetes management 2Evidence for 'food addiction' in humans 2
One-step, microplate or cuvet, colorimetric, detection range 0.04% to 4%. Procedure: 30 min....
... monoclonal [APS 26] to Presenilin 2 ... form of the disease carry mutations in ... amyloid precursor protein (APP). These disease-linked mutations ... form of amyloid-beta (main component of amyloid ...
One-step, microplate or cuvet, colorimetric, linear detection range 0.7 mg/dL to 35 mg/dL. Procedure: 5 min....
One-step, microplate or cuvet, colorimetric, linear detection range 0.9 mg/dL to 200 mg/dL. Procedure: 2 min....
Biology Products: